MARSHALL WACE, LLP - SPECTRUM PHARMACEUTICALS INC ownership

SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 174 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 2.23 and the average weighting 0.0%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of SPECTRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$1,232,000
-54.9%
969,105
+205.7%
0.00%
-90.9%
Q2 2019$2,729,000
+3398.7%
316,970
+3445.5%
0.02%
+2100.0%
Q4 2018$78,000
-98.1%
8,940
-96.2%
0.00%
-94.1%
Q3 2018$4,004,000238,3520.02%
Other shareholders
SPECTRUM PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 787,973$615,0000.77%
CM Management, LLC 600,000$468,0000.50%
ARMISTICE CAPITAL, LLC 17,100,000$13,338,0000.23%
Sargent Investment Group, LLC 614,600$479,0000.15%
Ergoteles LLC 744,275$581,0000.02%
Sonora Investment Management Group, LLC 103,000$80,0000.01%
CAXTON ASSOCIATES LP 107,135$84,0000.01%
MCDONALD PARTNERS LLC 42,570$33,0000.01%
Pinz Capital Management, LP 15,600$12,0000.01%
D. E. Shaw & Co., Inc. 8,051,858$6,281,0000.01%
View complete list of SPECTRUM PHARMACEUTICALS INC shareholders